's Avatar

@dairegannon.bsky.social

Postdoctoral researcher at WEHI

41 Followers  |  46 Following  |  3 Posts  |  Joined: 11.05.2025
Posts Following

Posts by (@dairegannon.bsky.social)

Preview
Accessory subunits of PRC2 mimic H3K27me3 to restrict the spread of Polycomb domains Some proteins mimic the repressive mark H3K27me3, but the physiological relevance of this phenomenon was unclear. Agius et al. show that the PRC2 subunits JARID2 and PALI1 mimic H3K27me3 to antagonize...

1/ 🧡 In our new paper, we show that JARID2 and PALI1 mimic H3K27me3 to antagonise PRC2. www.cell.com/molecular-ce...

04.03.2026 23:58 β€” πŸ‘ 55    πŸ” 23    πŸ’¬ 1    πŸ“Œ 2
Video thumbnail

1/ πŸš€ AEBP2 isn’t what we thought.

You were told that AEBP2 promotes PRC2 activity on chromatin.

We found the opposite: the most prevalent AEBP2 isoform inhibits PRC2 activity.

πŸ‘‰ surl.li/cgwqcq

A thread 🧡

31.10.2025 10:53 β€” πŸ‘ 40    πŸ” 16    πŸ’¬ 6    πŸ“Œ 2

We are delighted that @genesdev.bsky.social have selected our (w/ @adrianbracken.bsky.social) Weaver syndrome paper artwork as the November cover! This piece was made by my incredibly talented niece, Gina 'Dna Vinci' Ronan.

@ucddublin.bsky.social @tcddublin.bsky.social @ucd-sbbs.bsky.social

03.11.2025 18:17 β€” πŸ‘ 15    πŸ” 5    πŸ’¬ 1    πŸ“Œ 0
Post image

Congratulations to the winners of the 2025 AEpiA Emma Whitelaw Publication Award!

🧬 1st place: @shellainasci.bsky.social
🧬 2nd place: @victoriasugrue.bsky.social
🧬 3rd place: @dairegannon.bsky.social

This award recognises outstanding publications by ECRs in the field of epigenetics.

20.10.2025 06:16 β€” πŸ‘ 13    πŸ” 4    πŸ’¬ 1    πŸ“Œ 1

Absolutely delighted to share our preprint, using functional genomics to uncover a novel dependency in lymphoma that can overcome resistance to targeted therapy. Grateful to co-first author @jamesnolan.bsky.social and co-senior authors @conwayer1.bsky.social and @adrianbracken.bsky.social seeπŸ‘‡

17.10.2025 14:07 β€” πŸ‘ 5    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
Preview
AEBP2-Directed H3K27me2 Defines a Specific Vulnerability in EZH2-mutant Lymphoma The catalytic subunit of Polycomb Repressive Complex 2 (PRC2), EZH2, is recurrently mutated in 25% of diffuse large B-cell lymphomas (DLBCL), causing increased H3K27me3 and decreased H3K27me2 levels. ...

🧡1/Exciting news in cancer epigenetics! Our latest research, "AEBP2-Directed H3K27me2 Defines a Specific Vulnerability in EZH2-mutant Lymphoma", is now available on www.biorxiv.org/content/10.1.... Here's a thread summarizing our findings!πŸ‘‡
#CancerResearch #Epigenetics #Chromatin #Lymphoma

17.10.2025 07:10 β€” πŸ‘ 23    πŸ” 10    πŸ’¬ 1    πŸ“Œ 2

Thanks Jongmin!

07.06.2025 02:44 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Not all CBXs are created equal: A role for the disordered central region of CBX4 in pediatric glioma In this issue, Lagan et al.1 apply genome-wide and tiling-scan CRISPR screens to uncover a key role for CBX4 and its central region in promoting the growth of diffuse midline glioma cells bearing the ...

Great to see @jongminkmg.bsky.social’s preview of our work in @cp-molcell.bsky.social today!
www.cell.com/molecular-ce...

06.06.2025 08:37 β€” πŸ‘ 4    πŸ” 2    πŸ’¬ 1    πŸ“Œ 1
A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma Lagan, Gannon, et al. reveal that H3K27M-DMGs depend on a specific form of cPRC1 containing CBX4 and PCGF4. H3K27M alters H3K27me3 distribution, causing increased binding of CBX4-PCGF4-cPRC1 and oncogenic gene repression. CBX4’s ability to read H3K27me3 and to form a specific cPRC1 complex with PCGF4 makes it essential in DMG.

Online Now: A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma Online now:

21.05.2025 15:19 β€” πŸ‘ 6    πŸ” 5    πŸ’¬ 0    πŸ“Œ 0

Our work identifying CBX4 as a potential therapeutic target for diffuse midline glioma has just been published in Molecular Cell! Check out co-first author @eimearlagan.bsky.social’s overview below.

21.05.2025 21:25 β€” πŸ‘ 7    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0